Citation only
via OpenAlex
The Relationship Between Adrenomedullin, Metabolic Factors, and Vascular Function in Individuals With Type 2 Diabetes
Su Chi Lim, Nils G. Morgenthaler, Tavintharan Subramaniam, Yew Seng Wu, Siew Kheng Goh, Chee Fang Sum
Diabetes Care · 2007 · ▲ 53 citations
Abstract
OBJECTIVE: Subjects with type 2 diabetes are at risk for vascular injury. Several vasoactive factors (e.g., angiotensin) have been implicated. We hypothesize that adrenomedullin, a novel vascoactive factor, is deranged in subjects with type 2 diabetes. RESEARCH DESIGN AND METHODS: Using a new immunoluminometric method, plasma midregional proadrenomedullin (MR-proADM) was measured in four groups of Chinese subjects: healthy (n = 100, fasting plasma glucose [FPG] <5.6 mmol/l), impaired fasting glucose (IFG) (n = 60, FPG 5.6-6.9 mmol/l), and diabetic subjects with (n = 100) and without (n = 100) nephropathy. Resting forearm cutaneous microcirculatory perfusion (RCMP) was quantified in vivo using 2-dimensional laser Doppler flowmetry. We investigated the relationship between plasma MR-proADM concentrations, multiple metabolic factors, and vascular function. RESULTS: We observed a stepwise increase in MR-proADM among the groups: healthy group mean +/- SD 0.27 +/- 0.09, IFG group 0.29 +/- 0.13, diabetic group 0.42 +/- 0.13, and diabetic nephropathy group 0.81 +/- 0.54 nmol/l (diabetic vs. healthy and IFG groups, P = 0.04; and diabetic nephropathy group vs. all, P < 0.01). Statistical adjustment for sex, age, BMI, and blood pressure did not affect the conclusions. Multiple linear regression analysis revealed that highly sensitive C-reactive protein (beta = 0.11; P = 0.01), insulin resistance index (beta = 0.20; P = 0.001), LDL cholesterol (beta = 0.31; P < 0.001), and adiponectin (beta = 0.33; P < 0.001) were significant predictors of plasma MR-proADM concentrations among nondiabetic individuals. Among subjects with diabetes, plasma MR-proADM concentrations correlated significantly with RCMP (r = 0.43, P = 0.002). CONCLUSIONS: Plasma MR-proADM concentration was elevated in subjects with type 2 diabetes. This was further accentuated when nephropathy set in. MR-proADM was related to multiple metabolic factors and basal microcirculatory perfusion. Adrenomedullin might play a role in the pathogenesis of diabetic vasculopathy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2337/dc06-1899
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Lim, S.C., Morgenthaler, N.G., Subramaniam, T., Wu, Y.S., Goh, S.K., & Sum, C.F. (2007). The Relationship Between Adrenomedullin, Metabolic Factors, and Vascular Function in Individuals With Type 2 Diabetes. <em>Diabetes Care</em>. https://doi.org/10.2337/dc06-1899
Vancouver
Lim SC, Morgenthaler NG, Subramaniam T, Wu YS, Goh SK, Sum CF. The Relationship Between Adrenomedullin, Metabolic Factors, and Vascular Function in Individuals With Type 2 Diabetes. Diabetes Care. 2007. doi:10.2337/dc06-1899.
BibTeX
@article{su2007TheRel,
title = {The Relationship Between Adrenomedullin, Metabolic Factors, and Vascular Function in Individuals With Type 2 Diabetes},
author = {Su Chi Lim and Nils G. Morgenthaler and Tavintharan Subramaniam and Yew Seng Wu and Siew Kheng Goh and Chee Fang Sum},
journal = {Diabetes Care},
year = {2007},
doi = {10.2337/dc06-1899},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2012
Open access · CC-BY
Plasma and Muscle Myostatin in Relation to Type 2 Diabetes
Diabetes 2002
Open access · OA
Association of Adiponectin Mutation With Type 2 Diabetes
Metabolic Syndrome and Related Disorders 2007
Citation only
Metabolic Syndrome in Type 2 Diabetes Mellitus in Isfahan, Iran: Prevalence and Risk Factors
DOAJ (DOAJ: Directory of Open Access Journals) 2016
Preprint · CC-BY
A NEW MARKER OF METABOLIC DISORDERS IN MEN WITH TYPE 2 DIABETES
Diabetes Care 2005
Open access · OA
Effect of Sibutramine on Weight Management and Metabolic Control in Type 2 Diabetes
Metabolites 2026
Open access · CC-BY